Elisabet de los Pinos

elisabet-de-los-pinos.jpgEli is the Founder & CEO at Aura Biosciences Inc. a recently funded Cambridge (MA) based Biotech company developing a breakthrough technology to make new targeted drugs in oncology.

The company is the Next Generation Biotech model, with multiple research collaborations in Germany and the UK and a top US Management Team located in Boston.

Advisors to the company include last year´s Nobel Laureate in Medicine Harald Zur Hausen and world opinion leaders in oncology like Professor Daniel Von Hoff among others.

Prior to founding Aura, Eli worked at Pharmaceutical giant Eli Lilly and held several academic positions at Mount Sinai Institute of Molecular Medicine in NYC and at the Institute of Cancer Research in London.

Eli has a PhD in Molecular Biology from the University of Barcelona, an MBA from IE Business School and an executive degree in Entrepreneurship from MIT.